80 related articles for article (PubMed ID: 10667239)
1. B4112, a novel tetramethylpiperidine-substituted phenazine that inhibits the proliferation of multidrug-resistant cancer cell lines.
Van Rensburg CE; Jooné G; Van Niekerk E; Anderson R
Ann N Y Acad Sci; 1999; 886():280-2. PubMed ID: 10667239
[No Abstract] [Full Text] [Related]
2. Tetramethylpiperidine-substitution increases the antitumor activity of the riminophenazines for an acquired multidrug-resistant cell line.
van Rensburg CE; Jooné GK; O'Sullivan JF
Anticancer Drug Des; 2000 Aug; 15(4):303-6. PubMed ID: 11200506
[TBL] [Abstract][Full Text] [Related]
3. Tetramethylpiperidine-substituted phenazines inhibit the proliferation of intrinsically multidrug resistant carcinoma cell lines.
van Niekerk E; O'Sullivan JF; Jooné GK; van Rensburg CE
Invest New Drugs; 2001; 19(3):211-7. PubMed ID: 11561677
[TBL] [Abstract][Full Text] [Related]
4. Novel tetramethylpiperidine-substituted phenazines are potent inhibitors of P-glycoprotein activity in a multidrug resistant cancer cell line.
Van Rensburg CE; Anderson R; Jooné G; Myer MS; O'Sullivan JF
Anticancer Drugs; 1997 Aug; 8(7):708-13. PubMed ID: 9311448
[TBL] [Abstract][Full Text] [Related]
5. In vitro investigation of the antimicrobial activities of novel tetramethylpiperidine-substituted phenazines against Mycobacterium tuberculosis.
van Rensburg CE; Jooné GK; Sirgel FA; Matlola NM; O'Sullivan JF
Chemotherapy; 2000; 46(1):43-8. PubMed ID: 10601797
[TBL] [Abstract][Full Text] [Related]
6. [Flavopiridol, a cyclin-dependent kinase inhibitor].
Lansiaux A; Bailly C
Bull Cancer; 2000 Oct; 87(10):697-701. PubMed ID: 11084532
[No Abstract] [Full Text] [Related]
7. Antimicrobial activities of seven novel tetramethylpiperidine-substituted phenazines against multiple-drug-resistant Gram-positive bacteria.
Huygens F; O'Sullivan JF; van Rensburg CE
Chemotherapy; 2005 Aug; 51(5):263-7. PubMed ID: 16103666
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and cytotoxicity evaluation of 6,11-dihydro-pyridazo- and 6,11-dihydro-pyrido[2,3-b]phenazine-6,11-diones.
Lee HJ; Kim JS; Park SY; Suh ME; Kim HJ; Seo EK; Lee CO
Bioorg Med Chem; 2004 Apr; 12(7):1623-8. PubMed ID: 15028255
[TBL] [Abstract][Full Text] [Related]
9. Cell-killing activity and kinetic analysis of a novel antitumor compound NC-190, a benzo[a]phenazine derivative.
Nakaike S; Yamagishi T; Nanaumi K; Otomo S; Tsukagoshi S
Jpn J Cancer Res; 1992 Apr; 83(4):402-9. PubMed ID: 1506275
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antiproliferative activity of novel polynuclear heterocyclic compounds derived from 2,3-diaminophenazine.
Mahran AM; Ragab SSh; Hashem AI; Ali MM; Nada AA
Eur J Med Chem; 2015 Jan; 90():568-76. PubMed ID: 25497130
[TBL] [Abstract][Full Text] [Related]
11. Mode of action of the novel phenazine anticancer agents XR11576 and XR5944.
Lewis LJ; Mistry P; Charlton PA; Thomas H; Coley HM
Anticancer Drugs; 2007 Feb; 18(2):139-48. PubMed ID: 17159600
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.
Robey RW; Medina-Pérez WY; Nishiyama K; Lahusen T; Miyake K; Litman T; Senderowicz AM; Ross DD; Bates SE
Clin Cancer Res; 2001 Jan; 7(1):145-52. PubMed ID: 11205902
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of tetramethylpiperidine-substituted phenazines against Mycobacterium leprae in vitro.
Franzblau SG; White KE; O'Sullivan JF
Antimicrob Agents Chemother; 1989 Nov; 33(11):2004-5. PubMed ID: 2692516
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a human colorectal carcinoma cell line with acquired resistance to flavopiridol.
Smith V; Raynaud F; Workman P; Kelland LR
Mol Pharmacol; 2001 Nov; 60(5):885-93. PubMed ID: 11641415
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of normal and malignant cell proliferation by pyocyanine and 1-hydroxyphenazine.
Sorensen RU; Fredricks DN; Waller RL
Antibiot Chemother (1971); 1991; 44():85-93. PubMed ID: 1801650
[No Abstract] [Full Text] [Related]
16. In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer.
Chien M; Astumian M; Liebowitz D; Rinker-Schaeffer C; Stadler WM
Cancer Chemother Pharmacol; 1999; 44(1):81-7. PubMed ID: 10367753
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative activity of 2-alkyl-4-halopiperidines and 2-alkyl-4-halo-1,2,5,6-tetrahydropyridines in solid tumor cell lines.
León LG; Carballo RM; Vega-Hernández MC; Martín VS; Padrón JI; Padrón JM
Bioorg Med Chem Lett; 2007 May; 17(10):2681-4. PubMed ID: 17376681
[TBL] [Abstract][Full Text] [Related]
18. Antimycobacterial action of B4128, a novel tetramethylpiperidyl-substituted phenazine.
Matlola NM; Steel HC; Anderson R
J Antimicrob Chemother; 2001 Feb; 47(2):199-202. PubMed ID: 11157907
[TBL] [Abstract][Full Text] [Related]
19. Resistance to the new anti-cancer phospholipid ilmofosine (BM 41 440).
Hofmann J; Utz I; Spitaler M; Hofer S; Rybczynska M; Beck WT; Herrmann DB; Grunicke H
Br J Cancer; 1997; 76(7):862-9. PubMed ID: 9328144
[TBL] [Abstract][Full Text] [Related]
20. A lymphoma cell line resistant to 4-piperidinopiperidine was less sensitive to CPT-11.
Onishi Y; Oguro M; Kizaki H
Cancer Chemother Pharmacol; 1997; 39(6):473-8. PubMed ID: 9118457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
